Ignite Creation Date:
2024-05-06 @ 6:19 PM
Last Modification Date:
2024-10-26 @ 2:46 PM
Study NCT ID:
NCT05627427
Status:
RECRUITING
Last Update Posted:
2022-11-25
First Post:
2022-11-15
Brief Title:
Multi-cohort Study of Surufatinib Plus Sintilimab in Metastatic NEN and Pancreatic Carcinoma Who Failed Standard Chemotherapy
Sponsor:
Tianjin Medical University Cancer Institute and Hospital
Organization:
Tianjin Medical University Cancer Institute and Hospital
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Pancreatic Carcinoma |
| Neuroendocrine Tumor Grade 3 |
| Neuroendocrine Carcinoma |
Keywords: